可生物降解的协调纳米药物可以增强光动力疗法和肺癌免疫疗法
Jingyao Li1, Huixi Yi1, Yuanyuan Fu1
1Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, The Fifth Affiliated Hospital and School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
Journal of colloid and interface science
|November 3, 2024
概括
这项研究引入了与协调的新型纳米药物,可以对抗瘤缺氧和免疫抑制. 这些纳米药物增强光动力疗法 (PDT) 和免疫疗法,导致显著的瘤抑制,毒性最小.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 缺氧在固体瘤中普遍存在,产生免疫抑制性瘤微环境 (TME) 并降低光动力学治疗 (PDT) 的疗效.
- 瘤缺氧和免疫抑制是癌症治疗的主要挑战,需要新的治疗策略.
研究的目的:
- 通过调节TME来开发具有酸度反应的,可生物降解的协调纳米药物 (IPC),以增强PDT和免疫疗法.
- 调查IPC纳米药物在缓解瘤缺氧,增强癌细胞死亡和刺激抗瘤免疫力的有效性.
主要方法:
- IPC纳米药物是使用离子,e6 (Ce6) 和聚烯立合成的.
- 评估了纳米药物在激光照射时催化过氧化,耗尽谷和产生反应性氧物种 (ROS) 的能力.
- 在体外和体内研究评估了对瘤生长,TME调节和毒性的治疗作用.
主要成果:
- IPC纳米药物有效地缓解了瘤缺氧,并在癌细胞内耗尽了谷氨.
- 这些纳米药物放大了PDT反应,导致更多的免疫细胞死亡,并增强了ROS的产生.
- 在体内观察到显著的协同抑制瘤生长,具有强大的抗瘤免疫力和逆转的免疫抑制TME.
结论:
- 响应酸度的IPC纳米药物显示出对缺氧瘤的强有力的联合治疗效果.
- 这些纳米药物为调节TME提供了一个有希望的策略,增强PDT的疗效,并为癌症联合治疗提供了新的方法.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
484
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
484


